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Abstract.  Malaria  is  a  vector-borne  infection  caused  by  unicellular  parasite  of  the  genus 
Plasmodium.  Plasmodia are obligate  intracellular  parasites that are  able  to infect  and  replicate 
within  the  erythrocytes  after  a  clinically  silent
(P.falciparum,  P.malariae,  P.ovale
natural infection in human beings but the recent upsurge of 
has led clinicians to consider it as the fifth human malaria parasite. Recent studies in wild
apes in Africa have revealed that 
human-host restricted as previously believed and its phylogenetic lineage
with new species identified in gorilla, bonobo and chimpanzee. Although less impressive, new data 
on biology of P.malariae, P.ovale and 
review. 
Introduction. Four host-restricted or adapted species 
of  Plasmodium are  traditionally  recognized  as 
responsible of human malaria: Plasmodium falciparum
P.malariae, P.ovale and P.vivax.
1 Occasionally, human 
beings can be infected either naturally or accidentally 
by  several  simian  species  such  as 
cynomolgi,  P.cynomolgi  bastianelli
P.brasilianum, P.schwetzi, P.inui and P.knowlesi
latter emerged as an important cause of human malaria 
in  South-East  Asia, especially the  Malaysian Borneo 
since  2004  and  will  be  discussed  together  with  the 
other human plasmodia.
2
Plasmodia have been regarded as belonging to the 
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borne  infection  caused  by  unicellular  parasite  of  the  genus 
are obligate  intracellular  parasites that are  able  to infect  and  replicate 
within  the  erythrocytes  after  a  clinically  silent replication  phase  in  the  liver.  Four  species 
P.ovale and  P.vivax)  are  traditionally  recognized  as  responsible  of 
natural infection in human beings but the recent upsurge of P.knowlesi malaria in South
s to consider it as the fifth human malaria parasite. Recent studies in wild
apes in Africa have revealed that P.falciparum, the most deadly form of human malaria, is not only 
host restricted as previously believed and its phylogenetic lineage
with new species identified in gorilla, bonobo and chimpanzee. Although less impressive, new data 
and P.vivax are also emerging and will be briefly discussed in this 
restricted or adapted species 
are  traditionally  recognized  as 
Plasmodium falciparum, 
Occasionally, human 
beings can be infected either naturally or accidentally 
by  several  simian  species  such  as  P.  cynomolgi 
P.cynomolgi  bastianelli,  P.simiovale, 
P.knowlesi.
1 The 
nt cause of human malaria 
East  Asia, especially the  Malaysian Borneo 
since  2004  and  will  be  discussed  together  with  the 
have been regarded as belonging to the 
phylum  Apicomplexa  with  an  evolution  from  the 
Coccidian  stem  that  encompass  the  progressive 
acquisition of more complicated phases in  their life
cycles confined to a single host . Finally, the successful 
survival of these parasites requires completion of life 
cycle in two alternative hosts of evolutionarily d
species  (i.e. human  and  mosquito).The  genus 
Plasmodium    is  subdivided  in  the  sub
Plasmodium and  Laverania 
Haemosporidiidea (Table 1
Plasmodium contains three genomes: 1) a nuclear 
genome  that  comprises  14  linear  chromos
linear mitochondrial genome that is one of the smallest 
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replication  phase  in  the  liver.  Four  species 
)  are  traditionally  recognized  as  responsible  of 
malaria in South-East Asia 
s to consider it as the fifth human malaria parasite. Recent studies in wild-living 
, the most deadly form of human malaria, is not only 
is much more complex 
with new species identified in gorilla, bonobo and chimpanzee. Although less impressive, new data 
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with  an  evolution  from  the 
n  stem  that  encompass  the  progressive 
acquisition of more complicated phases in  their life-
cycles confined to a single host . Finally, the successful 
survival of these parasites requires completion of life 
cycle in two alternative hosts of evolutionarily distant 
human  and  mosquito).The  genus 
is  subdivided  in  the  sub-genus 
Laverania  within  the  sub-order 
Table 1). 
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genome  that  comprises  14  linear  chromosomes;2)  a 
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Table  1.  Classification  of  human  protozoa  of  the  genus 
Plasmodium
Domain Eukaryota
Kingdom Chromalveolata
Superphylum Alveolata
Phylum Apicomplexa
Class Aconoidasida
Order  Haemosporida 
Sub-order Haemosporidiidea
Family  Plasmodiidae
Genus  Plasmodia
Sub-genus Plasmodium; Laverania
Species
P.falciparum
P.malariae
P.ovale
P.vivax
P.knowlesi*
*  P.knowlesi is  a  primary  parasite  of  monkey  that  can  infect
humans
known ; 3) a 35 kb circular plastid genome of red-algal 
origin, that is housed in the apicoplast.
The  life  cycle  of  all  species  of  human  malaria 
parasites  is  characterized  by  an  exogenous  sexual 
phase  (named  sporogony),  in  which  multiplication 
occurs in several species of Anopheles mosquitos, and 
an  endogenous  asexual  phase  (named  schizogony) 
which  take  place  in  the  vertebrate  host.
1 The  latter 
phase  begins  when  sporozoites  following  the 
inoculation by mosquito, enter the parenchymal cells of 
liver,  and  undergo  their  development  and 
multiplication  ,  a  process  that  is  known  as  ,  pre-
erythrocytic schizogony. In the vertebrate host the life 
cycle of Plasmodium is characterized by a tissue phase 
in  the  liver,  followed  by  a  blood  phase,  that  is 
ultimately  responsible  of  the  appearance  of  clinical 
manifestations.  It  is  generally  believed  that  once  an 
infectious  female  anopheline  mosquito  injects 
sporozoites in the blood, they are able to travel quickly 
to the liver where they invade the host’s hepatocytes. 
However, new findings seems to indicate the existence 
of a more complex invasion process characterized by 
the  persistence  of  sporozoites  in  human  dermis  for 
hours  with  a slow release into  capillaries as  well  as 
migration through lymphatic system.
3,4 In the liver the 
sporozoites undergo their replication becoming a tissue 
schizont that contains thousands of merozoites (about 
10,000  in  P.vivax/P.ovale and  up  to  30,000  in 
P.falciparum).  This  exoerythrocytic  schizogony  is 
characteristic  of  each  species  and  takes  a  minimum 
maturation  time  of  6  days  in  P.falciparum and  a 
maximum  of  16  days  in  P.malariae.  The  mature 
schizont  ruptures  (together  with  the  infected 
hepatocytes)  releasing  merozoites  that  once  in  the 
blood  actively  invade  erythrocytes  using  an  acto-
myosin  motor  system.  The  tissue  phase  extinguishes 
itself at this point with the notable exception of P.vivax
and P.ovale (and certain other primate species such as 
P.cynomolgi)  who  are  able  to  persist  in  the  liver  as 
“hypnozoites” that are eventually  responsible of  the 
phenomenon of relapse. The blood cycle begins when 
the merozoites invade the erythrocytes and the period 
of time from the  infection by  mosquito bite and the 
first appearance of the trophozoites in the erythrocytes
is  called  “prepatent  period”  ;  this  period  is 
characteristic  of  each  species  and  is  constant.  The 
prepatent  period  lasts  9  days in  P.falciparum,  11-13 
days  in  P.vivax,  10-14  days  in  P.ovale,  15  days  in 
P.malariae and  9-12   days  in  P.knowlesi (Table 2). 
Within the erythrocytes, trophozoites mature over the 
course  of  24-72  hours,  a  phenomenon  that  is  again 
species-dependent,  with  the  production  of  blood-
schizonts each one containing 6 to 36 merozoites. The 
rupture of erythrocytes releases into the blood a new 
wave  of  merozoites  that  are  able  to  infect  other 
erythrocytes. The rupture of the schizonts is followed 
by  the  appearance  of  the  malaria  febrile  paroxysm 
classically lasting 8 to 12 hours ( “Golgi cycle”) and 
characterized by three stages : 1) the cold stage marked 
by  the  rapid  rise  of  the  temperature  associated  with 
chills; 2) the hot stage with the temperature peak , skin 
vasodilatation, headache, myalgias; 3) the sweat stage 
with defervescence. However, it should be noted that 
the appearance of typical febrile periodicity (tertian or 
quartan  fever)  requires  the  synchronization  of  the 
blood parasite cycles and since symptomatic cases of 
malaria are usually observed earlier than in the past, 
this feature is now rarely encountered in the clinical 
practice  in  western  countries.  During  the  process  of 
schizogony  some of  the  merozoites differentiate  into 
sexual  forms- female  (macrogametocytes)  and  -male 
(microgametocytes),  respectively,  which  are 
responsible,  if  ingested  by  a  female  anopheline 
mosquito  of  the  definite  sporogonic  cycle.  It  was 
initially  believed  that  gametocytes  persisted  in  the 
blood for long periods of time but, a study by Hawking 
and coworkers ,conducted on P.knowlesi, P.cynomolgi
and  P.cathemerium (a  duck  Plasmodium)  contrasted 
this view.
5 They showed that gametocytes develop to 
the  stage  of  infectivity  for  mosquitoes  a  few  hours 
longer than their asexual cycle and then remain mature 
for  only  a  short  period  of  hours  (5-12)  finally 
degenerating  and  disappearing  from  the  blood.  The 
molecular mechanism that triggers the development of 
gametocytes as well as the factors that determine the 
sex  of  gametocytes  are  poorly  understood;  however, 
duration and stages of gametocytogenesis vary among 
Plasmodium species.
The  sexual  development  of  malaria  parasite 
(sporogonic  cycle)  will  be  completed  only  whenMediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table 2. Characteristics of infection with the five species of Plasmodia infecting humans
Characteristics Plasmodium 
falciparum P.knowlesi P.malariae P.ovale P.vivax
Pre-erythrocytic stage  
(days) 5-7 8-9 14-16 9 6-8
Pre-patent period (days) 9-10 9-12 15-16 10-14 11-13
Erythrocytic cycle (days) 48 24 72 50 48
Red cells affected All All Mature erythrocytes Reticulocytes Reticulocytes
Parasitaemia per µL
 Average
 Maximum
20,000-500,000
2,000,000
600-10,000
236,000
6000
20,000
9000
30,000
20,000
100,000
Febrile paroxysm (hours) 16-36 or longer 8-12 8-10 8-12 8-12
Severe malaria Yes Yes No No Yes
Relapses from liver forms No No No Yes Yes
Recurrences Yes (treatment 
failure) Yes
Yes (as long as 30-50 
years after primary 
attack)
No Yes (treatment 
failure)
mature female and male gametocytes are ingested by a 
biologically  suitable  species  of  female  Anopheles 
mosquito during a blood meal. A mosquito blood meal 
is, on average, 2 to 3 µL, and should contain at least 
one male and one female gametocyte to be infective.
Host  location  by  the  mosquito  is  mediated  by 
physical (heat, moisture, visual) and chemical cues that 
play  a  role  during  orientation  and  landing. 
6,7 It  is 
known that skin bacteria play an important role in the 
production  of  human  body  odour  and  convert  non-
volatile  compounds  into  volatile  compounds  with 
characteristic  smells.  In  a  recent  elegant  experiment  
Verhulst et al. studied the attractiveness of 48 human 
males  to  Anopheles  gambiae (a  nocturnal  highly 
anthropophilic species) one of the major malaria vector 
in  Africa.  They  showed  that  individuals  with  higher 
skin  microbial  diversity  and  higher  abundance  of 
Pseudomonas and Variovorax spp. were less attractive 
to the mosquitoes and hypothesized an in-built defence 
system  controlled  by  the  Major  Histocompatibility 
Complex genes.
8
Once  in  the  midgut  of  the  insect  the 
macrogametocyte  (i.e. female)  is  released  by  the 
erythrocytes  to  became  a  macrogamete  (within  5 
minutes)  whereas  the  male  counterpart 
(microgametocyte)  divides  its  nucleus  more  slowly 
(about 20 minutes) into eight flagellated microgametes 
responsible  of  the  fertilization  of  macrogamete  a 
process that takes one hour.
9 The zygote that is formed 
by the fusion of the two nuclei evolved into a slowly 
motile ookinete that actively penetrate the peritrophic 
membrane and the midgut epithelium. Twenty-four to 
forty-eight  hours  after  the ingestion  of  blood,  the 
oocyst develops and, subsequently, its single nucleus 
divides  repeatedly  until  the  formation  of  a  mature 
oocyst that contains thousands of sporozoites. The time 
span required to development of mature oocyst is quite 
variable (7-30 days), characteristic of each species and 
influenced  by  ambient  temperature.  Oocyst 
development  is  the  longest  developmental  phase  as 
well as the only extracellular of the Plasmodium life 
cycle. The sporozoites actively escape from the oocyst 
and  only  25  % of  those liberated by oocyst  migrate 
through the hemocoelomic fluid to the acinal cells of 
salivary glands, where after about a day of residence, 
they became highly infective.
10 They are irreversibly 
programmed  for  their  journey  in  the  vertebrate  host 
because they completely lost their capacity to re-infect 
salivary  glands.
10 Once  that  the  mosquito  bites  the 
piercing proboscis probes the dermis for a blood vessel 
and ejects saliva, which, via its anticoagulant activity, 
facilitates blood ingestion.
11 Sporozoites present in the 
salivary  ducts  are  ejected  during  skin  probing  in  a 
number generally not exceeding 10-100.
Plasmodium  falciparum.  Plasmodium  (Laverania) 
falciparum (Welch, 1896) is the highly pathogenic and 
most deadly parasite causing malaria in humans. It was 
discovered  in  1880  by  Charles  Alphonse  Laveran,  a 
French  Army  Surgeon,    deployed  in  Constantine 
(Algeria) and originally named by himself Oscillaria 
malariae.
12 Examining under a microscope a drop of 
blood  from  a  young  soldier  with  fever,  Laveran 
observed  some  spherical  and  crescent-shaped  bodies 
with  actively  moving  filaments  ;  he  was  looking  at 
exflagellation of a male gametocytes of P.falciparum a 
phenomenon  that  was  subsequently  explained  by 
Maccallum.
13 Exflagellation of the microgametocyte in 
the  life  cycle  of  malarial  parasites  occurs  in  the 
stomach of mosquitoes after ingestion of an infected 
blood meal but in rare cases it can be observed also in 
the  peripheral  blood  smear  of  infected  humans, 
generally as the consequence of extended delay in slide 
preparation or following warming.
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Eighty-five  countries  are  actually  classified  as 
endemic  for  P.falciparum malaria  with  2.57  billion 
people  living in  area  at  risk for  transmission of this 
infection.
15 Of these, 1.44 billion people live in area of 
stable  transmission,  mainly  in  Africa  (52%  of  the 
global total) and Central, South and East Asia (46%).
16
The estimate of the burden of P.falciparum clinical 
malaria  is  a  difficult  task  complicated  by  several 
factors  such  as  inadequate  and  incomplete  national 
reporting  systems  and  inaccurate  diagnoses  with 
possible overestimate disease rates. By using improved 
cartographic  and  epidemiological  data  sources 
combined  with  geostatistical  space-time  joint 
simulation framework, Hay and coworkers, estimated
that in 2007 there were 451 (95 % confidence interval 
349-553)  million  clinical  cases  of  P.falciparum
malaria.
17 Sixty  percent  (271  million)  occurred  in 
Africa (including Saudi Arabia and Yemen), and 39 % 
in the 19 countries of Central and South East (CSE) 
Asia with the highest-burden countries being Nigeria 
and Democratic Republic of Congo in Africa and India 
and Myanmar in CSE Asia region.
16 These figures are 
in contrast with the most recent estimates by the WHO 
that reported in 2010 an estimated 216 million (149-
274  million)  episodes  of  malaria  worldwide  with 
655,000 deaths (537,000-907,000).
18
The  whole  genome  of  P.falciparum has  been 
sequenced  and  published  in  2002    being  a  major 
advance  in  the  struggle  against  this  lethal  parasite.
19
The  nuclear  genome,  distributed  in  14  linear 
chromosomes, consists of about 5,365 genes of whom 
1,817 have known functions (Table 3). Of these 1,817 
functional  genes  of  P.falciparum,  81.6  %  have  been 
shown to be conserved with those of P.vivax and only 
334 genes (18.5%) were unique to the former species.
20
In comparison with P.vivax and P.knowlesi genomes, 
P.falciparum shows  an  higher  content  of  A+T  and 
despite having the smallest genome size it displays the 
highest content of simple sequence repeats (SSRs) that 
are supposed to be responsible of genome complexity 
responsible for rapid evolutionary adaptation  (Table 
3).
21 The proteomic characterization of the four stages 
of  the  parasite  life  cycle  (sporozoite,  merozoite, 
trophozoite, gametocyte) showed that about half of the 
sporozoite  proteins  are  unique  to  this  stage  whereas 
trophozoite, merozoite and gametocytes  had between 
20 % and 30 % unique proteins.
22 Moreover only 152 
proteins (6%) were shared to all four stages and the 
high degree of proteome diversity of each stage of the 
Plasmodium life cycle suggested a highly coordinated 
expression  of  genes  involved  in  common  process. 
However,  the  comparative  genomics  analyses  of 
Plasmodium genomes  indicated  the  genes  mediating 
parasite-host interactions are frequently restricted to a 
single  Plasmodium species.  For  P.falciparum,  the 
P.falciparum erythrocyte  membrane  protein  1 
(PfEMP1) that is known to be encoded by about 60 
members of the specific var gene family, is considered 
the principal virulence factor of P.falciparum because 
PfEMP1 proteins, expressed on the surface of infected 
erythrocytes,  are  able  to  mediate  adhesion  to  both 
uninfected and host endothelial cells.
19
The exoerythrocytic schizogony of P.falciparum is 
a rapid process that is usually completed in five and 
half  days  with  the  production  of  a  schizont, 
characterized by bizarre forms, containing a very high 
number of merozoites. Following the rupture of liver 
schizonts,  each  released  merozoite  invade  an 
erythrocyte  a  complex  process  that  requires  a 
recognition  between  receptors  (on  erythrocyte)  and 
ligands  (on  merozoite).  In  the  case  of  P.falciparum, 
early  studies  identified  as  possible  receptors  for 
merozoite invasion sialic acid, glycophorin A, B and 
C.
23-25 Another  sialic  acid-independent  erythrocyte 
receptor  for  P.falciparum  adhesin  PfRh4,  the 
complement  receptor  1  (CR1) has  been  identified in 
2010.
26 However, none of these receptor-ligand pairs 
were shown to be essential in all parasite strains tested. 
More  recently,  Crosnier  and  colleagues  identified 
basigin,  an  antigen  of  the  Ok  blood  group  ,  as  the 
receptor  essential  for  the  erythrocyte  invasion  by 
P.falciparum.
27 Basigin  is  also  known  as  CD147, 
EMMPRIN  and  M6  and  is  a  member  of  the 
immunoglobulin superfamily (IgSF) that is implicated 
in many biological functions. In more detail, basigin 
proved to be a receptor for the PfRh5 a unique protein 
among the EBAs and Rhs that cannot be deleted in any 
P.falciparum strain.
27
Erythrocytic  schizogony  is  characterized  by  the 
appearance in  the  blood  of young  rings  whereas  the 
maturation  stages  are  rarely  seen  in  the  peripheral 
blood.  There  is  no  enlargement  of  the  infected 
erythrocytes  during  the  development  and  the  mature 
schizont  usually  contains  8-32  merozoites.  The 
gametocytes  of  P.falciparum develop  in  the  internal 
organs and do not appear until about eight to ten days 
after  the  start  of  parasitaemia.  P.falciparum
gametocytogenesis has been characterized through five 
morphologically  distinct  substages.
28,29 Immature 
P.falciparum gametocytes (stage I-IV) are sequestered 
away from circulation and only the  mature crescent-
shaped  gametocytes  (stage  V)  are  released  in 
peripheral blood where they finally become infectious 
to mosquitoes.
29
Until  the  last  year,  the  closest  ancestor  of 
P.falciparum was  considered  to  be  a  chimpanzee 
parasite,  P.reichenowi,  which  was  believed  to  have 
diverged from its human counterpart 5-7 Myears.
30-32
However, a recent paper, published in 2010 , in whom 
the Authors analyzed more than 2500 samples of ape Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table 3. Comparative genome size , whole genome SSR , A+T and G+C content of the three sequenced genome of Plasmodium species 
causing human malaria
Plasmodium species Overall genome 
size (Mb)
Number of 
genes
*
Overall SSR 
content (%)
Overall A+T 
content (%)
Overall G+C content 
(%)
Plasmodium vivax 26.8 5,433 3.8 58 42.3
Plasmodium knowlesi 23.5 5,188 4.92 63 37.5
Plasmodium falciparum  23.3 5,403 10.5 81 19.4
* Including  pseudogenes and  partial  genes,  excluding  non-coding  RNA  genes;  SSR=simple  sequence  repeats;  A=adenine;  T=thymine;
G=guanine; C=cytosine
fecal material as a source of Plasmodium DNA, using a 
single-genome  amplification  strategy,  challenged  this 
view.
33 The Authors, claimed that human P.falciparum
sequences constitute a single lineage nested within the 
G1  clade  of  gorilla  parasites  thus  suggesting  that 
human  P.falciparum is  of  gorilla  origin  and  not  of 
chimpanzee.
33,34 Moreover, several papers published in 
2010,  showed  that  P.falciparum,  once  considered 
strictly  human  specific,  can  infect  bonobos, 
chimpanzees and gorillas and thus these African apes 
might serve also as possible reservoir for the malignant 
form  of  human  malaria.
35-38 In this  regard,  five  new 
phylogenetic  species  within  the  Laverania subgenus 
have been identified in just one year providing a new 
representation  of  the  phylogeny  with  two  groups. 
Group  A  that  includes  three  species  :  P.GorA (that 
infects  Gorillas),  P.gaboni and  P.billbrayi (both 
infecting  chimpanzees)  and  group  B  that  includes 
P.falciparum and  P.reichenowi and  P.GorB (that 
infects  gorillas)  and  P.billcollinsi (that  infects 
chimpanzees).
39 Finally,  researchers  from  USA, 
confuted  the  new  view  that  P.falciparum was 
transferred by gorilla to human and on the basis of their 
analysis of 45 orthologous gene sequences , indicated 
that ape infections with P.falciparum might be a very 
recent phenomena.
40
Plasmodium  vivax.  Plasmodium  vivax (Grassi  and 
Feletti, 1890) is responsible of the so called “benign 
tertian  fever”  although  the  lack  of  life-threatening 
complications associated with this infection have been 
recently  questioned  by  several  reports.
41,42 It  was 
identified as a separate malaria parasite together with 
P.malariae in 1886 by Camillo Golgi who described 
the typical “tertian” and “quartan” fever paroxisms and 
confuted the Laveran’s postulate of the existence of a 
single  malaria  species.
43 In  1890  Giovan  Battista 
Grassi  and  Raimondo  Feletti  named  them 
Haemamoeba  vivax and  H.malariae.
44 The  whole 
genome of P.vivax Salvador I strain was sequenced and 
published  in  2008:  with  its  26.8-megabase  (Mb) 
nuclear genome is higher than that of P.falciparum and 
displays chromosomes that are unique among human 
Plasmodium species  with  an  isochore  structure.
45 It 
contains  5,433  predicted  protein  coding  genes  and 
represents  the  most  GC-rich  (42.3  %)  Plasmodium
genome sequenced to date (Table 3). A recent analysis 
of proteome of P.vivax was able to identify 7 proteins 
which were entirely specific to P.vivax and 16 proteins 
that did not share any homology in P.falciparum (2 Vir
and  8  P-fam proteins)  probably  implicated  in 
virulence/antigenicity of P.vivax.
46
Plasmodium vivax is present throughout the tropics 
with low rate of infection in western and central sub-
Saharan Africa. According to recent estimates 40% of 
the world’s population (2.6 billion people) is at risk of 
P.vivax transmission  with  between  130-435  million 
clinical episodes of vivax malaria each year.
47,48 The 
origin  of  P.vivax has  been  ,  as  in  the  case  of 
P.falciparum,  a  debatable  question  with  different 
hypotheses; the  abundance of simian malaria species 
observed  in  Southeast  Asia  together  with 
morphological and biological characteristics shared by 
P.vivax with macaque parasites where the arguments 
used to place the origin of P.vivax in Southeast Asia.
49
On  the  contrary,  the  high  prevalence  of  Duffy 
negativity  (i.e.  the  lack  of  the  Duffy  blood  group 
antigen)  among  human  population  throughout  sub-
Saharan Africa has been indicated to argue an African 
origin  for  P.vivax
50 Subsequent  studies  using  data 
regarding  complete  mitochondrial  genomes  and 
nuclear  and  plastid  genes  argued  that  P.vivax was 
introduced into Homo sapiens in Asia by a species of 
Plasmodium parasitic to macaques.
51-53
Sporozoites  of  P.vivax,  once  in  the  liver, 
differentiate either into early, primary tissue schizonts 
or  into  hypnozoites  which  are  responsible  for  late 
relapse  of  the  infection.  The  term  “hypnozoite” was 
probably coined and adopted for malaria by Markus in 
1978 whereas the biological proof of the existence of 
hypnozoites is the direct consequence of the work by 
Krotoski and coworkers.
54-56
The biological determinant that supports the active 
or  dormant  development  pathway  is  still  unknown 
although the relapsing nature of P.vivax malaria was 
described  at  the  end  of  nineteen  century by  Thayer, 
Bignami and Manson as outlined in the recent elegant 
review by White.
57
During the erythrocytic development of P.vivax all 
forms can be found in the peripheral blood and in most Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
stages the appearance is larger that in the other species 
of  human  Plasmodia.  It  is  also  responsible  of  the 
enlargement  of  host  cells  thus  increasing  its 
deformability.
1 The  parasite  preferentially  invades 
young red blood cells (i.e reticulocytes) an issue that 
seems to limit its reproductive capacity with level of 
parasitaemia  that  rarely  exceed  2  %  of  circulating 
erythrocytes. The invasion of erythrocytes by P.vivax
merozoites requires interaction with the Duffy antigen 
receptor for chemokines (DARC) with Duffy-negative 
individuals considered to be naturally resistant to this 
human  malaria  parasite.
58 The  high  proportion  of 
Duffy-negative people in West and Central Africa has 
long be viewed as the most plausible explanation of the 
rarity of P.vivax malaria in those geographical areas. 
However, in recent years several investigators either in 
Africa  and  South America  were  able  to  demonstrate 
that P.vivax has evolved  and adapted in a way that 
circumvent  this  pathway  and  it  is  able  to  invade 
erythrocytes  also  in  individuals  who  lack  the  Duffy 
antigen on their red cells.
59-61 The young throphozoite 
grows  rapidly  and  exibits the  characteristic  malaria 
pigment; subsequently it assumes an amoeboid activity 
and a large vacuole forms a “hole” within the ring until 
the division of the nucleus begins. The mature schizont 
contains on average 12 to 18 merozoites and fills the 
entire host cell.
1,49
Gametocytes production probably start with the first 
generation  of  merozoites  of  P.vivax and  can  be 
detected within 3 days after the first asexual parasites 
are observed.
29
One  of  the  most  intriguing  and  debatable  issue 
regarding P.vivax is whether or not it exists as a single 
species  or  on  the  contrary  different  species  or  sub-
species are represented.
62-64 Li and coworkers showed 
that  P.vivax comprises  two  distinct  lineages  with 
phenotypic  difference  with  respect  to  their  preferred 
mosquito  vector  and  with  a  distinct  chromosomal 
translocation.
65 On  the  basis  of  differences  on  the 
incubation period and on relapse intervals it has been 
known  for  a  long  that  different  phenotypes  (P.vivax
Chesson,  P.vivax Madagascar,St.Elizabeth,  P.vivax
North Korean, P.vivax Hibernans) are  responsible of 
different presentation.
62,63 Madagascar and St.Elizabeth 
strains (considered the typical P.vivax) usually cause a 
primary illness two weeks after mosquito inoculation 
with  subsequent  relapse  after  an  interval  of  7-10 
months  but  with  shortened  subsequent  inter-relapse 
intervals.  On  the  contrary  the  P.vivax hibernans
(distributed in northern Europe and Russia) presented a 
primary  infection  8-10  months  after  inoculation. 
Finally  ,  the  P.vivax Chesson  strain  shows  very 
frequent  relapses  and  high  relapse  rate.  The  exact 
trigger  for  the  activation  of  hypnozoites  is  not 
understood and various theories such external stresses, 
seasonal  stimuli  or  mosquito  bites,  have  been 
proposed.
57,64
In  the  Anopheles  mosquito,  after  fertilization  the 
sexual cycle takes 8-10 days at 28 °C and 16 days at 20 
°C  whereas  below  15  °C  the  completion  of  the 
sporogonic cycle is unlikely.
1
Plasmodium ovale. Plasmodium ovale (Stevens, 1922)
was discovered in 1922 by Stephens who observed it in 
the  blood  of  an  East  african  patient  with  malaria 
erythrocytes with oval shape and fimbriated edges and 
named the parasite P.ovale.
66 Using the sequences of 
the small subunit ribosomal RNA (SSUrRNA) gene it 
has been established that P.ovale belong to 2 genetic 
haplotypes  named  classic  and  variant.
67 Both  the 
classical  and  variant  types  are  morphologically 
indistinguishable and occurred in sympatry worldwide 
; based on the observation that no evidence of inter-or 
intragenic  recombination  could  be  observed  among 
samples  coming  from  different  part  of  the  world, 
Sutherland and coworkers raised the possibility of the 
existence  of  2  species  and  proposed  to  name  these 
species  P.ovale  curtisi (classic  type)  and  P.ovale 
wallikeri (variant type) in honour of 2 malariologists : 
Christofer  Curtis  (1939-2008)  and  David  Walliker 
(1940-2007).
68,69 P.ovale is distributed in sub-Saharan 
Africa,  South-east  Asia  (Philippines,  Myanmar, 
Vietnam,  Thailand)  ,  Middle  East,  the  Indian 
subcontinent, Papua New Guinea and Irian Jaya  and 
East Timor in Indonesia ; it has never been reported 
from South America.
70 It has been estimated that the 
global burden of P.ovale in Africa might exceeds 15 
million cases annually.
68 The prepatent period (i.e. the 
interval between sporozoites inoculation and the first 
detection of parasites in peripheral blood) of P.ovale is 
between 12 and 20 days , with a median of 14,5 days.
71
Parasitaemia  is  usually  low  during  P.ovale infection 
probably as the consequence of restricted development 
in  younger  erythrocytes;  in  a  study  regarding  90 
patients the maximum parasite levels ranged between 
380  and  27,660/µL  with  a  mean  maximum  parasite 
level of 6,944/µL.
71 The changes produced by P.ovale
on the infected erythrocytes are similar to those seen in 
P.vivax whereas  the  schizonts  and  gametocytes  may 
resemble those of P.malariae.
1 The completion of the 
sporogonic cycle in the mosquito takes 12-14 days at 
28 °C. 
P.ovale is  generally  regarded  as  responsible  of  a 
relapsing  infection  originating  from  dormant
(“hypnozoites”) exo-erythrocytic stages in the liver.
1,71
According  to  Collins  and  Jeffery,  the  only 
demonstration of the existence of liver hypnozoites in 
human was that of Garnham and coworkers who made 
a liver biopsy in a volunteer that was deliberately fed 
by  Anopheles mosquitoes  infected  with  a  Liberian Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
strain of P.ovale.
71,72 However, in a recent provocative 
article by Richter and colleagues, the Authors reported 
the  rarity of relapses in naturally acquired infections 
and  hypothesized that  some  of  these  cases  might  be 
due  to  P.vivax misidentified  as  P.ovale.
73 Moreover, 
they  claimed  that  in  P.ovale infection,  hypnozoites 
have  never  been  demonstrated  by  biological 
experiments but in their paper failed to cite the work by 
Garnham.
72,73 After treatment of a primary attack the 
relapse interval for P.ovale has been described to be in 
the  range  of  17  to  255  days;
71 however,  delayed 
primary attacks have been observed after as long as 4 
years and in a recent paper of mostly PCR confirmed 
cases of P.ovale , a primary attack was observed after 
53 months.
74,76
Recently in a study conducted in Cameroon, Duval 
and  coworkers  found  for  the  first  time  two 
chimpanzees  infected  by  human  P.ovale a  condition 
that  raise  the  possibility  that  cross-species  exchange 
might be more important than previously thought with 
the potential role of African great apes as reservoir for 
human malaria parasites.
77
Plasmodium  malariae.  Plasmodium  malariae
(Laveran, 1880), responsible of the “quartan malaria”, 
is  present  worldwide  in  all  major  malaria-endemic 
regions but with a scattered distribution.
70,78 Infections 
caused  by  P.malariae are  most  common  in  sub-
Saharan  Africa  and  southwest  Pacific  and  less 
frequently encountered in Asia, Middle East, Central 
and South America. As for P.vivax also for P.malariae
the relationship between the life cycle of development 
(respectively 48- and 72-hours) and the periodicity of 
the  fever  paroxysm  were  elegantly  explained  by 
Camillo Golgi in 1886 although the two parasites were 
identified as separate species by Grassi and Feletti.
43,44
The parasite is characterized by a slow development 
either  in  the  Anopheles mosquito  (15  days)  and  in 
human (15 days in the liver, 72 hours in the blood). 
P.malariae is  considered  to  be  the  precursor  of 
P.brasilianum a  parasite  that  infects  New  World 
monkeys  and  has  naturally  adapted  to  it;
1,78 both 
Plasmodia are  able  to  infect  either  humans  and 
monkeys.  P.malariae is  responsible  of  low  grade 
parasitaemia  ,  rarely  exceeding  30,000  parasites  per 
microliter,  probably  as  a  consequence  of  the  low 
number of merozoites produced per erythrocytic cycle 
together with the 72-hour developmental cycle and the 
preference to infect older erythrocytes. The pre-patent 
period  for  P.malariae is  extremely  variable  with  a 
range of 16 to 59 days. No quiescent liver stage forms 
have been identified for P.malariae but this parasite is 
able to persist in the blood with low level parasitaemia 
for extremely long periods and perhaps for the entire 
life of the human host causing recrudescence even after 
more  than  30-40  years  or  longer.
1,78-80 Moreover, 
chronic P.malariae infection was linked to nephrotic 
syndrome in Nigerian children about 50 years ago, and 
it  is  believed  to  be  caused  by  immune  complex 
deposition on the basement membrane.
81,82 The young 
trophozoites are similar to those of P.vivax (although 
their cytoplasm is thicker and they stain more deeply); 
a characteristic feature of P.malariae is the appearance 
of band form with the trophozoite that stretch across 
the entire width of the cell. The mature schizont has an 
average of 8 merozoites that are sometimes arranged 
symmetrically  around  the  centre  with  a  daisy 
appearance.
1 The  sporogonic  cycle  in  the  Anopheles
mosquito takes 30-35 days at 20°C but may be as short 
as 14 days at 28°C.
Plasmodium knowlesi. Plasmodium knowlesi (Sinton 
and Mulligan 1932) is a simian plasmodium that was 
probably  first  described  by  the  Italian  malariologist 
Giuseppe  Franchini  in  the  blood  of  Macaca 
fascicularis. 
83,84 Subsequently  it  was  studied  by 
Napier, Campbell, Das Gupta and Knowles and finally 
was completely characterized by Sinton and Mulligan 
who named it P.knowlesi in honour and acknowledging 
the original work of Dr Knowles.
85-87 P.knowlesi was 
employed in the treatment of general paresis of insane 
(i.e. neurosyphilis)  until  1955  when  it  was  finally 
abandoned  due  to  the  increased  virulence  of  the 
organisms after multiple passages in humans.
85,88 The 
first  natural  infection  of  humans  was  serendipity 
observed  in  an  American  Army  patient  who  was 
deployed  in  Peninsular  Malaysia  and  developed 
malaria  on  the  way  home.
89 The  availability  of 
molecular  diagnostic  tools  recently  helped  to 
distinguish P.knowlesi from P.malariae and to identify 
it as an important cause of human malaria not only in 
the Peninsular Malaysian Borneo but also in other parts 
of  South-east  Asia.
2,90 Phylogenically,  P.knowlesi is 
more closely related with P.vivax than other humans 
Plasmodia  and  in  a  similar  way  the  process  of 
merozoites  invasion  of  erythrocytes  requires  the 
interaction of Duffy-bindings proteins (DBP) with the 
Duffy antigen receptor for chemokines (DARC).
1,91,92
However,  important  phenotypic  differences  with 
P.vivax exists such as absence of a dormant liver stage, 
host blood cell preference  and length of asexual cycle. 
The  genome  of  P.knowlesi has  been  sequenced  and 
described showing important differences with those of 
P.falciparum and P.vivax (Table 3).
93 P.knowlesi was 
the first malaria parasite in which antigenic variation 
was demonstrated to occur.
94
Long-tailed  (Macaca  fascicularis)  and  pig-tailed 
macaques (M.nemestrina) are the main natural hosts of 
P.knowlesi.
85 After  infection,  all  the  developmental 
stages of the malaria parasite life-cycle are observed in Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
the peripheral blood. The intra-erythrocitic life-cycle is 
of 24 hours (unique for all malaria parasite of primates) 
with  an  asynchronous  development  and  it  is  not 
restricted  to  young  or  old  cells.
85,89 The  young  ring 
forms  appear very  similar  to  those  of  P.falciparum
whereas  during  subsequent  stage  of  maturation  the 
intra-erythrocyte  parasites  resemble  the  band  forms 
observed  in  P.malariae infection.
2,85 The  mature 
schizont contains as many as 16  merozoites  with an 
average  of  10.  The  sexual  forms  grow  more  slowly 
than  asexual  forms  and  take  usually  48  hours  to 
complete  their development; the  macrogametocyte  at 
the end of maturation is spherical with a blue-stained 
cytoplasm  and  fills  the  host  cell  whereas  the 
microgametocyte  is  sometimes  smaller  and  with  a 
pink-stained cytoplasm. High level of parasitemia and 
severe manifestations resembling those of P.falciparum
malaria  have  been  described  for  P.knowlesi with  a 
possible lethal outcome.
94,95
Conclusions. Our knowledge of the biology of human 
malaria parasites has dramatically improved in the last 
few years thanks to the whole sequencing of DNA of 
the  two  most  important  human  Plasmodia: 
P.falciparum and P.vivax. Moreover, the introduction 
of  molecular  techniques  has  greatly  improved  the 
identification of malaria parasites at the species level. 
In  this  regard  ,  the  availability  of  species-specific 
polymerase  chain  reaction  allowed  Balbir  Singh  and 
his  coworkers  to  recognize  the  significant  role  of 
P.knowlesi,  a  natural  plasmodia  of  macaques,  as  a 
cause  of  human  malaria  in  the  Southeast  Asia. This 
discovery,  together  with  the  possibility  to  use  non-
invasive methods to supply animal DNA, renewed the 
interest to study malaria parasite of apes increasing the 
membership  clade  of  P.falciparum and  P.ovale and 
finally  showing  that  P.falciparum is  diverse and  not 
human-host restricted.
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